When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 11 Hits
  • Search Condition : Filter (MeSH = Herpesvirus 1, Human / genetics*)
Species Resource Title
Human and Animal Cells TGBC1TKB(RCB1129) , TGBC2TKB(RCB1130) Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters.
Human and Animal Cells Vero(RCB0001) Involvement of herpes simplex virus type 1 UL13 protein kinase in induction of SOCS genes, the negative regulators of cytokine signaling.
Human and Animal Cells OV2944-HM-1(RCB1483) Oncolytic viral therapy with a combination of HF10, a herpes simplex virus type 1 variant and granulocyte-macrophage colony-stimulating factor for murine ovarian cancer.
Human and Animal Cells G-361(RCB0991) , Vero(RCB0001) Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
Human and Animal Cells Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
Human and Animal Cells Vero(RCB0001) , COS-7(RCB0539) Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus.
Human and Animal Cells Vero(RCB0001) , T24(RCB0431) , MBT-2(RCB0544) Herpes simplex virus type 1 mutant HF10 oncolytic viral therapy for bladder cancer.
Human and Animal Cells 143B/TK^(-)neo^(R)(RCB0701) Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.
Human and Animal Cells J774.1(RCB0434) Participation of type I interferon in the decreased virulence of the UL13 gene-deleted mutant of herpes simplex virus type 1.
Human and Animal Cells Vero(RCB0001) Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancer.
DNA material pKM2L-phMK (RDB05514) Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine-positive tumors.